Clinical Trial for Triple Negative Breast Cancer
Links shared publicly online about this topic.
- 120total visits
Clinical Trial for Triple Negative Breast Cancer
View full resource at oncologytube.com
Tags: Cancer, Breast Cancer, Clinical Trial, Women's Health, Oncology, Education, Medical, Medicine
Most Recently Shared on July 25, 2011 at 7:49 pm By:
RT @oncologytube: #Oncology Clinical Trial for Triple Negative Breast Cancer http://bit.ly/oepeFn
Mayo Clinic - Mayo Clinic — TGen Study Role Testosterone May Play in Triple Negative Breast Cancer
mayoclinic.org — “Mayo Clinic - Mayo Clinic — TGen Study Role Testosterone May Play in Triple Negative Breast Cancer” View full resource at mayoclinic.org
Most Recently Shared on March 26, 2012 at 2:24 pm By:
TGen Study Role Testosterone May Play in Triple Negative Breast Cancer http://t.co/ZtQWwPGY from Mayo Clinic AZ
Testosterone may play a role in treatment of triple negative breast cancer
news-medical.net — “Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows the testosterone receptor may be a potential target to attack in treating triple negative breast cancer (TNBC).” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 4:01 pm By:
Testosterone may play a role in treatment of triple negative breast cancer: Could blocking a testosterone recept... http://t.co/WXw6ppYW
Study role testosterone may play in triple negative breast cancer
medicalxpress.com — “Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. Preliminary results of a Mayo Clinic - TGen collaborative study shows ...” View full resource at medicalxpress.com
Most Recently Shared on March 23, 2012 at 1:26 pm By:
PhysOrg Health News Health News
Study role testosterone may play in triple negative breast cancer http://t.co/zSdIdQMV
SABCS: Loss of RB in Triple Negative Breast Cancer Associated with Favorable Clinical Outcome
newswise.com — “Researchers at the Thomas Jefferson University Hospital and Kimmel Cancer Center at Jefferson have shown that loss of the retinoblastoma tumor suppressor gene (RB) in triple negative breast cancer patients is associated with better clinical outcomes. This is a new marker to identify the subset of these patients who may respond positively to chemotherapy.” View full resource at newswise.com
Most Recently Shared on December 12, 2011 at 8:41 pm By:
New biomarker identified to help #breast #cancer patients decide if chemotherapy is right for them. http://t.co/P8VboP8Q #womenshealth
NursingCenter
nursingcenter.com — “. NursingCenter.com... Over 900 CE activities and thousands of clinical articles from over 50 leading Lippincott Williams & Wilkins nursing journals, including: The American Journal of Nursing, Nursing2007, Nursing Management, The Nurse Practitioner, Nursing Made Incredibly Easy, and many more specialty journals.” View full resource at nursingcenter.com
Most Recently Shared on October 20, 2011 at 1:52 am By:
Lisa Morris Bonsall Nurse and Advanced Practice Nurse
Triple-Negative Breast Cancer Characteristics Identified http://t.co/VayD3DTX
Breast Cancer - OncLive
onclive.com — “Breast Cancer articles, resources, clinical trials and videos for the Oncologist specializing in the care of breast cancer, metastatic breast cancer and triple-negative breast cancer” View full resource at onclive.com
Most Recently Shared on October 9, 2011 at 12:20 am By:
Articles, resources, and multimedia focused on Breast Cancer http://ow.ly/6R1du #breastcancer
Medical News: ASCO: Platinum Chemo Equivalence Questioned - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- All platinum chemotherapy agents may not be as equally effective as often assumed, according to exploratory findings from a trial in metastatic triple-negative breast cancer.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:05 pm By:
Roger D. Jones, PhD Health Social Media, PhD, Doctor, and Health Executive
Medical News: ASCO: Platinum Chemo Equivalence Questioned - http://t.co/V8IE3id from @medpagetoday #health #medicine
Medical News: ASCO: PARP Drug Fails to Slow Triple-Negative Breast Ca - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Promising early results in metastatic triple-negative breast cancer failed to hold up in a phase III trial of the PARP inhibitor iniparib, according to data reported here.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 6:44 pm By:
Roger D. Jones, PhD Health Social Media, PhD, Doctor, and Health Executive
Medical News: ASCO: PARP Drug Fails to Slow Triple-Negative Breast Ca - http://t.co/z7NUVrE from @medpagetoday #health #medicine
Interim Safety Data Compared in Ixabepilone TITAN Trial
onclive.com — “Researchers are continuing to explore whether ixabepilone (Ixempra) is a better choice as adjuvant chemotherapy for patients with early-stage, triple-negative breast cancer than the standard paclitaxel (Taxol).” View full resource at onclive.com
Most Recently Shared on July 18, 2011 at 5:22 pm By:
Interim Safety Data Compared in Ixabepilone TNBC TITAN Trial http://t.co/JSkXO8N #breastcancer #tnbc
Propolis contains a compound which inhibits triple negative breast cancer in the animal model. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine
greenmedinfo.com — “This article on GreenMedInfo.com concerns - Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.” View full resource at greenmedinfo.com
Most Recently Shared on July 5, 2011 at 10:24 pm By:
Medical News: ASCO: PARP Drug Fails to Slow Triple-Negative Breast Ca - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Promising early results in metastatic triple-negative breast cancer failed to hold up in a phase III trial of the PARP inhibitor iniparib, according to data reported here.” View full resource at medpagetoday.com
Most Recently Shared on June 10, 2011 at 6:46 pm By:
ASCO: PARP Drug Fails to Slow Triple-Negative Breast Ca (CME/CE) http://bit.ly/mH226R
Medical News: ASCO: Platinum Chemo Equivalence Questioned - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- All platinum chemotherapy agents may not be as equally effective as often assumed, according to exploratory findings from a trial in metastatic triple-negative breast cancer.” View full resource at medpagetoday.com
Most Recently Shared on June 7, 2011 at 9:42 pm By:
ASCO: Platinum Chemo Equivalence Questioned http://bit.ly/lL7fnS
Medical News: ASCO: Platinum Chemo Equivalence Questioned - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- All platinum chemotherapy agents may not be as equally effective as often assumed, according to exploratory findings from a trial in metastatic triple-negative breast cancer.” View full resource at medpagetoday.com
Most Recently Shared on June 7, 2011 at 8:43 pm By:
Drugs and Devices OW OW Health
ASCO: Platinum Chemo Equivalence Questioned: CHICAGO -- All platinum chemotherapy agents may not be as equ... http://bit.ly/kKeEau #drug
Iniparib + Gemcitabine/Carboplatin Did Not Improve Overall or Progression-Free Survival in Metastatic Breast Cancer - MPR
empr.com — “The addition of iniparib to gemcitabine/carboplatin did not meet prespecified criteria for significance for co-primary endpoints of overall survival and progression-free survival in patients with metastatic triple-negative breast cancer, according to results of a study presented at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at empr.com
Most Recently Shared on June 7, 2011 at 2:29 pm By:
#asco2011 Iniparib + Gemcitabine/Carboplatin Did Not Improve Overall or Progression-Free… http://goo.gl/fb/0KDl3
Advertisement
